BVS (STOCKS)
Bioventus Inc. Class A Common Stock
$8.630000
+0.120000 (+1.41%)
Prev close: $8.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Robert Claypoole
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $718.40M
- Employees
- 950
- P/E (TTM)
- 20.86
- P/B (TTM)
- 3.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.15 | $0.10 | +0.0515 | +52.28% |
|
Dec 2025 (Q4)
|
$0.24 | $0.22 | +0.0212 | +9.69% |
|
Sep 2025 (Q3)
|
$0.15 | $0.12 | +0.0338 | +29.09% |
|
Jun 2025 (Q2)
|
$0.21 | $0.21 | -0.0021 | -0.99% |
Financial Statements
| Revenues | $576.30M |
| Benefits Costs and Expenses | $542.66M |
| Cost Of Revenue | $180.43M |
| Costs And Expenses | $542.66M |
| Gross Profit | $395.87M |
| Nonoperating Income/Loss | -$23.88M |
| Operating Expenses | $338.35M |
| Selling, General, and Administrative Expenses | $318.85M |
| Depreciation and Amortization | $5.24M |
| Research and Development | $11.57M |
| Other Operating Expenses | $2.69M |
| Operating Income/Loss | $57.52M |
| Income/Loss From Continuing Operations After Tax | $34.54M |
| Income/Loss From Continuing Operations Before Tax | $33.64M |
| Income Tax Expense/Benefit | -$899.00K |
| Net Income/Loss | $34.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $6.06M |
| Net Income/Loss Attributable To Parent | $28.48M |
| Net Income/Loss Available To Common Stockholders, Basic | $28.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.43 |
| Diluted Earnings Per Share | $0.41 |
| Basic Average Shares | 200,860,935 |
| Diluted Average Shares | 207,505,615 |
| Assets | $650.54M |
| Current Assets | $249.81M |
| Inventory | $83.19M |
| Other Current Assets | $166.63M |
| Noncurrent Assets | $400.73M |
| Intangible Assets | $359.66M |
| Other Non-current Assets | $41.07M |
| Liabilities | $416.27M |
| Current Liabilities | $148.10M |
| Accounts Payable | $24.05M |
| Other Current Liabilities | $124.05M |
| Noncurrent Liabilities | $268.18M |
| Equity | $234.27M |
| Equity Attributable To Noncontrolling Interest | $45.36M |
| Equity Attributable To Parent | $188.90M |
| Liabilities And Equity | $650.54M |
| Net Cash Flow From Operating Activities | $102.94M |
| Net Cash Flow From Operating Activities, Continuing | $102.94M |
| Net Cash Flow From Investing Activities | -$3.00M |
| Net Cash Flow From Investing Activities, Continuing | -$3.00M |
| Net Cash Flow From Financing Activities | -$86.23M |
| Net Cash Flow From Financing Activities, Continuing | -$86.23M |
| Exchange Gains/Losses | -$667.00K |
| Net Cash Flow | $13.04M |
| Net Cash Flow, Continuing | $13.71M |
| Comprehensive Income/Loss | $34.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $6.01M |
| Comprehensive Income/Loss Attributable To Parent | $28.27M |
| Other Comprehensive Income/Loss | $726.00K |